Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group
- PMID: 37752126
- PMCID: PMC10522653
- DOI: 10.1038/s41408-023-00924-5
Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- SEER*Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute; 2023 Apr 19. [cited 2023 May 31]. Available from: https://seer.cancer.gov/statistics-network/explorer/. Data source(s): SEER Incidence Data, November 2022 Submission (1975–2020), SEER 22 registries.
-
- Breese EH, Kotecha RS, Guest EM. Acute lymphoblastic leukemia in infants; a distinctive, high-risk subtype of childhood acute lymphoblastic leukemia. In: Litzow MR, Raetz EA, editors. Clinical management of acute lymphoblastic leukemia: from bench to bedside. Switzerland: Springer; 2022. pp. 135–48.
-
- Pieters R, de Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, et al. Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the Interfant-06 protocol: results from an international phase III randomized study. J Clin Oncol. 2019;37:2246–56. doi: 10.1200/JCO.19.00261. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
